iohexol has been researched along with Carcinoma, Non-Small Cell Lung in 17 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " After surgery, matched whole-tumor sections were stained for exogenous and endogenous markers of hypoxia (pimonidazole infused intravenously 24 hours before surgery, immediately after DCE CT; glucose transporter protein)." | 3.78 | Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia. ( Barber, PR; Bell, A; Burke, M; Daley, FM; Finch, J; Goh, V; Hoskin, PJ; Kozarski, R; Mandeville, HC; Ng, QS; Pierce, G; Townsend, ER; Vojnovic, B, 2012) |
| "Sensitivity and specificity were compared between these examinations using McNemar test." | 1.36 | Thin-section CT of the mediastinum in preoperative N-staging of non-small cell lung cancer: comparison with FDG PET. ( Araki, T; Ichikawa, T; Kato, S; Matsumoto, K; Motosugi, U; Nambu, A; Nishikawa, K; Okuwaki, H; Saito, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishino, M | 2 |
| Jackman, DM | 2 |
| DiPiro, PJ | 2 |
| Hatabu, H | 2 |
| Jänne, PA | 2 |
| Johnson, BE | 2 |
| Choi, CM | 1 |
| Kim, MY | 1 |
| Hwang, HJ | 1 |
| Lee, JB | 1 |
| Kim, WS | 1 |
| Yip, C | 1 |
| Tacelli, N | 2 |
| Remy-Jardin, M | 2 |
| Scherpereel, A | 2 |
| Cortot, A | 1 |
| Lafitte, JJ | 2 |
| Wallyn, F | 1 |
| Remy, J | 2 |
| Bassett, P | 1 |
| Siddique, M | 1 |
| Cook, GJ | 1 |
| Landau, DB | 1 |
| Goh, V | 2 |
| Andersen, MB | 1 |
| Harders, SW | 1 |
| Ganeshan, B | 1 |
| Thygesen, J | 1 |
| Torp Madsen, HH | 1 |
| Rasmussen, F | 1 |
| Li, X | 1 |
| Meng, X | 1 |
| Ye, Z | 1 |
| Nambu, A | 1 |
| Kato, S | 1 |
| Motosugi, U | 1 |
| Araki, T | 1 |
| Okuwaki, H | 1 |
| Nishikawa, K | 1 |
| Saito, A | 1 |
| Matsumoto, K | 2 |
| Ichikawa, T | 1 |
| Shi, W | 1 |
| Liu, C | 1 |
| Lu, B | 1 |
| Yeung, A | 1 |
| Newlin, HE | 1 |
| Amdur, RJ | 1 |
| Olivier, KR | 1 |
| Beland, MD | 1 |
| Wasser, EJ | 1 |
| Mayo-Smith, WW | 2 |
| Dupuy, DE | 2 |
| Lind, JS | 1 |
| Meijerink, MR | 1 |
| Dingemans, AM | 1 |
| van Kuijk, C | 1 |
| Ollers, MC | 1 |
| de Ruysscher, D | 1 |
| Postmus, PE | 1 |
| Smit, EF | 1 |
| Copin, MC | 1 |
| Mensier, E | 1 |
| Jaillard, S | 1 |
| Klotz, E | 1 |
| Duhamel, A | 1 |
| Guo, M | 1 |
| Yap, JT | 1 |
| Ho, TK | 1 |
| Van den Abbeele, AD | 1 |
| Mandeville, HC | 1 |
| Ng, QS | 1 |
| Daley, FM | 1 |
| Barber, PR | 1 |
| Pierce, G | 1 |
| Finch, J | 1 |
| Burke, M | 1 |
| Bell, A | 1 |
| Townsend, ER | 1 |
| Kozarski, R | 1 |
| Vojnovic, B | 1 |
| Hoskin, PJ | 1 |
| Grieco, CA | 1 |
| Simon, CJ | 1 |
| DiPetrillo, TA | 1 |
| Ready, NE | 1 |
| Ohno, Y | 1 |
| Koyama, H | 1 |
| Takenaka, D | 1 |
| Nogami, M | 1 |
| Kotani, Y | 1 |
| Nishimura, Y | 1 |
| Yoshimura, M | 1 |
| Yoshikawa, T | 1 |
| Sugimura, K | 1 |
| Plathow, C | 1 |
| Aschoff, P | 1 |
| Lichy, MP | 1 |
| Eschmann, S | 1 |
| Hehr, T | 1 |
| Brink, I | 1 |
| Claussen, CD | 1 |
| Pfannenberg, C | 1 |
| Schlemmer, HP | 1 |
| Yamashita, K | 1 |
| Matsunobe, S | 1 |
| Takahashi, R | 1 |
| Tsuda, T | 1 |
| Miki, H | 1 |
| Oyanagi, H | 1 |
| Konishi, J | 1 |
| Lum, PA | 1 |
| Davis, MJ | 1 |
| Orizaga, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase IV/II Open-label Study to Evaluate Prompt Response to Treatment With Cisplatin, Gemcitabine and Bevacizumab in Patients With Non-small Lung Cancer.[NCT02316327] | Phase 4 | 19 participants (Actual) | Interventional | 2013-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for iohexol and Carcinoma, Non-Small Cell Lung
13 other studies available for iohexol and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anaplastic Lymphoma Kinase; Biopsy, Needle; Bronchos | 2015 |
Imaging Tumor Response and Tumoral Heterogeneity in Non-Small Cell Lung Cancer Treated With Antiangiogenic Therapy: Comparison of the Prognostic Ability of RECIST 1.1, an Alternate Method (Crabb), and Image Heterogeneity Analysis.
Topics: Adult; Aged; Angiogenesis Inhibitors; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Contrast Media; F | 2015 |
CT texture analysis can help differentiate between malignant and benign lymph nodes in the mediastinum in patients suspected for lung cancer.
Topics: Adult; Carcinoma, Non-Small-Cell Lung; Contrast Media; Denmark; Diagnosis, Differential; Female; Hum | 2016 |
Iodine quantification to characterize primary lesions, metastatic and non-metastatic lymph nodes in lung cancers by dual energy computed tomography: An initial experience.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Diagnosis, Differential; Female; Humans; Iodine; Ioh | 2016 |
Thin-section CT of the mediastinum in preoperative N-staging of non-small cell lung cancer: comparison with FDG PET.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose | 2010 |
The effect of intravenous contrast on photon radiation therapy dose calculations for lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Fluorodeoxyglucose F18; Humans; Infusions, Intraveno | 2010 |
Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
Topics: Aged; Aged, 80 and over; Biopsy; Carcinoma, Non-Small-Cell Lung; Catheter Ablation; Contrast Media; | 2010 |
Assessment of non-small cell lung cancer perfusion: pathologic-CT correlation in 15 patients.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Contrast Media; Female; Humans; Iohex | 2010 |
CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cone-Beam Computed Tomography; Contrast Med | 2011 |
Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia.
Topics: Aged; Biomarkers, Tumor; Blood Volume; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Human | 2012 |
Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Catheter Ablation; Combined Modality Therap | 2006 |
Small peripheral lung carcinoma evaluated with incremental dynamic CT: radiologic-pathologic correlation.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Elastic Tissue; Female; Hu | 1995 |
Computed tomography fluid-fluid level in bone metastasis.
Topics: Bone Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Humans; Iohexol; Lung Neopl | 1990 |